Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 9, Pages 4894
Publisher
MDPI AG
Online
2022-04-29
DOI
10.3390/ijms23094894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A meta-analysis of the association between calprotectin and the severity of COVID-19
- (2022) Qin Mao et al. JOURNAL OF INFECTION
- Interleukin-6-Production Is Responsible for Induction of Hepatic Synthesis of Several Chemokines as Acute-Phase Mediators in Two Animal Models: Possible Significance for Interpretation of Laboratory Changes in Severely Ill Patients
- (2022) Ihtzaz Ahmed Malik et al. Biology-Basel
- Immune determinants of COVID-19 disease presentation and severity
- (2021) Petter Brodin NATURE MEDICINE
- The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression
- (2021) Wei Huang et al. JOURNAL OF IMMUNOLOGY
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature
- (2021) Ariel Munitz et al. Scientific Reports
- An open label trial of anakinra to prevent respiratory failure in COVID-19
- (2021) Evdoxia Kyriazopoulou et al. eLife
- IL-33 in COVID-19: friend or foe?
- (2021) Yuejin Liang et al. Cellular & Molecular Immunology
- Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19
- (2021) George N. Dalekos et al. European Journal of Internal Medicine
- Circulating Calprotectin as a Biomarker of COVID-19 Severity
- (2021) Michael Mahler et al. Expert Review of Clinical Immunology
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals
- (2021) Michal A. Stanczak et al. Nature Communications
- Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
- (2021) Evdoxia Kyriazopoulou et al. NATURE MEDICINE
- Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial
- (2021) Konstantinos Tsiakos et al. Infectious Diseases and Therapy
- Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
- (2021) Alexander J Mentzer et al. JOURNAL OF INFECTION
- ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients
- (2021) Eleni Karakike et al. Journal of Innate Immunity
- Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19
- (2021) Sarthak Sinha et al. NATURE MEDICINE
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
- (2020) Tobias Herold et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19
- (2020) Aymeric Silvin et al. CELL
- Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients
- (2020) Liting Chen et al. Cellular & Molecular Immunology
- Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
- (2020) Alessio Mazzoni et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-38 inhibits microglial inflammatory mediators and is decreased in amygdala of children with autism spectrum disorder
- (2020) Irene Tsilioni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highways to hell: mechanism based management of Cytokine Storm Syndromes
- (2020) Scott W. Canna et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Neutrophil calprotectin identifies severe pulmonary disease in COVID‐19
- (2020) Hui Shi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19
- (2020) Qirui Guo et al. Cell Host & Microbe
- Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department
- (2020) Wolfgang Bauer et al. JOURNAL OF INFECTION
- Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
- (2019) Alberto Mantovani et al. IMMUNITY
- Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin
- (2018) Alexandra Taracanova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biology of IL-38 and its role in disease
- (2017) Frank L. van de Veerdonk et al. IMMUNOLOGICAL REVIEWS
- SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors
- (2017) Alexandra Taracanova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intracellular interleukin (IL)-1 family cytokine processing enzyme
- (2016) Areum Kwak et al. ARCHIVES OF PHARMACAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started